BOULDER, Colo.--(BUSINESS WIRE)--Enveda, a biotechnology company using AI to translate nature into new medicines, announced today an oversubscribed $130 million Series C funding round led by Kinnevik ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback